NEW YORK, December 25, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (“Inotiv” or the “Company”) NOTV. Those investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, extension 7980.

The investigation concerns whether Inotiv and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On November 17, 2022, Inotiv announced in a Form 8-K filed with the United States (“US”) Securities and Exchange Commission that on November 16, 2022, the Company became aware that the U.S. Attorney’s Office for the Southern District of Florida, employees of the company’s main supplier of non-human primates (“NHPs”) have been criminally charged with conspiring to illegally import NHPs into the United States from December 2017 to January 2022 and in connection with seven specific imports between July 2018 and December 2021.

As a result of this news, Inotiv’s share price fell $9.03 per share, or 56.97%, to close at $6.82 per share on November 17, 2022.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris and Tel Aviv, is recognized as one of the leading law firms specializing in corporate, securities and antitrust litigation. Founded by the late Abraham L. Pomerantz, best known as Dean of the Class Bar Association, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he founded and fights for the rights of victims of securities fraud, fiduciary breaches and corporate wrongdoing. The firm has recovered numerous multi-million dollar claims on behalf of group members. See www.pomlaw.com.

CONTACT:
Robert S Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 ext. 7980